Cargando…

The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy

Patients with community-acquired pneumonia (CAP) in the hospital setting exhibit markedly abnormal levels of various biomarkers of infection, inflammation and coagulation. CAP is a well characterized disease, relatively homogeneous and amenable to management according to defined protocols. Hence, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mira, Jean-Paul, Max, Adeline, Burgel, Pierre-Regis
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607115/ https://www.ncbi.nlm.nih.gov/pubmed/19105798 http://dx.doi.org/10.1186/cc7028

Ejemplares similares

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Adjunctive and Supportive Measures for Community-Acquired Pneumonia
por: Waterer, G. W., et al.
Publicado: (2010)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Severity of community-acquired pneumonia treated with low-dose adjunctive corticosteroid
por: Mikami, Katsunaka, et al.
Publicado: (2011)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults
por: Chang, Catherina L., et al.
Publicado: (2013)

Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Marti, Christophe, et al.
Publicado: (2015)

What’s new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics
por: Torres, Antoni, et al.
Publicado: (2015)

Clinical muscle mass-related biomarkers that predict mortality in older patients with community-acquired pneumonia
por: Huang, Sha, et al.
Publicado: (2022)

Adjunct prednisone therapy for patients with community-acquired pneumonia: a randomized, placebo-controlled multicenter trial
por: Blum, CA, et al.
Publicado: (2015)

The Ongoing Quest for Predictive Biomarkers in Chronic Obstructive Pulmonary Disease
por: Regard, Lucile, et al.
Publicado: (2023)

Biomarkers in Pediatric Community-Acquired Pneumonia
por: Principi, Nicola, et al.
Publicado: (2017)

Predicting 1-year mortality after hospitalization for community-acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2018)

Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis
por: Bi, Jirui, et al.
Publicado: (2016)

Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis
por: Huang, Jing, et al.
Publicado: (2019)

Severe community acquired pneumonia update: mortality, mechanisms and medical intervention
por: Laterre, Pierre-Francois
Publicado: (2008)

The host response in different aetiologies of community-acquired pneumonia: Potential new targets for adjunctive treatments?
por: Vestergaard Jensen, Andreas
Publicado: (2022)

4221 Lower Serum TWEAK Concentration is a Biomarker for Mortality in Community Acquired Pneumonia
por: Parra, Daniela, et al.
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Antimicrobial therapy of community-acquired pneumonia
por: File, Thomas M., et al.
Publicado: (2004)

A mortality prediction rule for non-elderly patients with community-acquired pneumonia
por: Tashiro, Masato, et al.
Publicado: (2016)

Using Data-Driven Rules to Predict Mortality in Severe Community Acquired Pneumonia
por: Wu, Chuang, et al.
Publicado: (2014)

Risk Prediction Models for Mortality in Community-Acquired Pneumonia: A Systematic Review
por: Kwok, Chun Shing, et al.
Publicado: (2013)

Community-acquired pneumonia: comparison of three mortality prediction scores in the emergency department
por: Hincapié, Carolina, et al.
Publicado: (2021)

Effect of corticosteroids on mortality in patients with community-acquired pneumonia
por: Chen, Shangzhong, et al.
Publicado: (2023)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Biomarkers in Community-Acquired Pneumonia (Cardiac and Non-Cardiac)
por: Méndez, Raúl, et al.
Publicado: (2020)

Mucus Plugs in Medium-sized Airways: A Novel Imaging Biomarker for Phenotyping Chronic Obstructive Pulmonary Disease
por: Chassagnon, Guillaume, et al.
Publicado: (2021)

Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia
por: Quah, Jessica, et al.
Publicado: (2021)

Discovery and predictive modeling of urine microbiome, metabolite and cytokine biomarkers in hospitalized patients with community acquired pneumonia
por: Pierre, Joseph F., et al.
Publicado: (2020)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management
por: Que, Yok-Ai, et al.
Publicado: (2015)

Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children
por: Meyer Sauteur, Patrick M, et al.
Publicado: (2019)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Changing Bacteriological Profile and Mortality Trends in Community Acquired Pneumonia
por: Khadanga, Sagar, et al.
Publicado: (2014)

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia
por: Quah, Jessica, et al.
Publicado: (2018)

Population-based incidence and mortality of community-acquired pneumonia in Germany
por: Theilacker, Christian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ofpe3nv49ql43iies32u8c4sbt